EcoDrugPlus

C-X-C Motif Chemokine Receptor 2

Ensembl ID : ENSCPOG00000001412
Gene Symbol: CXCR2
3 Cross references
238 Possible Orthologues:

C-X-C Motif Chemokine Receptor 4

Ensembl ID : ENSCPOG00000014249
Gene Symbol: CXCR4
2 Cross references
218 Possible Orthologues:

Cf Transmembrane Conductance Regulator

Ensembl ID : ENSCPOG00000012767
Gene Symbol: CFTR
2 Cross references
217 Possible Orthologues:

Dna Methyltransferase 1

Ensembl ID : ENSCPOG00000019557
Gene Symbol: DNMT1
2 Cross references
212 Possible Orthologues:

Dna Topoisomerase I

Ensembl ID : ENSCPOG00000009076
Gene Symbol: TOP1
4 Cross references
273 Possible Orthologues:

Dna Topoisomerase Ii Alpha

Ensembl ID : ENSCPOG00000006799
Gene Symbol: TOP2A
2 Cross references
206 Possible Orthologues:

Dna Topoisomerase Ii Beta

Ensembl ID : ENSCPOG00000015416
Gene Symbol: TOP2B
4 Cross references
210 Possible Orthologues:

Emap Like 4

Ensembl ID : ENSCPOG00000014948
Gene Symbol: EML4
2 Cross references
214 Possible Orthologues:

Eph Receptor A2

Ensembl ID : ENSCPOG00000003065
Gene Symbol: EPHA2
2 Cross references
124 Possible Orthologues:

Eph Receptor A3

Ensembl ID : ENSCPOG00000004938
Gene Symbol: EPHA3
2 Cross references
216 Possible Orthologues:

Eph Receptor B4

Ensembl ID : ENSCPOG00000014491
Gene Symbol: EPHB4
4 Cross references
168 Possible Orthologues:

F2r Like Thrombin Or Trypsin Receptor 3

Ensembl ID : ENSCPOG00000040487
Gene Symbol: F2RL3
2 Cross references
193 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).